Cellular uptake but low permeation of human calcitonin-derived cell penetrating peptides and Tat(47-57) through well-differentiated epithelial models.
about
Applications and Challenges for Use of Cell-Penetrating Peptides as Delivery Vectors for Peptide and Protein CargosMetabolic cleavage of cell-penetrating peptides in contact with epithelial models: human calcitonin (hCT)-derived peptides, Tat(47-57) and penetratin(43-58)Translocation of cell penetrating peptide engrafted nanoparticles across skin layersCell-Penetrating Peptides Selectively Cross the Blood-Brain Barrier In Vivo.Cell-penetrating peptides for drug delivery across membrane barriers.Penetrating the cell membrane, thermal targeting and novel anticancer drugs: the development of thermally targeted, elastin-like polypeptide cancer therapeutics.Getting across the cell membrane: an overview for small molecules, peptides, and proteins.TAT-BoNT/A(₁₋₄₄₈), a novel fusion protein as a therapeutic agent: analysis of transcutaneous delivery and enzyme activity.Cell-penetrating peptides as tools to enhance non-injectable delivery of biopharmaceuticals.A microdevice for parallelized pulmonary permeability studies.Investigations into the fate of inhaled salmon calcitonin at the respiratory epithelial barrier.Calcium condensation of DNA complexed with cell-penetrating peptides offers efficient, noncytotoxic gene delivery.Membrane surface-associated helices promote lipid interactions and cellular uptake of human calcitonin-derived cell penetrating peptides.Cell-penetrating antimicrobial peptides - prospectives for targeting intracellular infections.Transport of surface-modified nanoparticles through cell monolayers.Unlocking Endosomal Entrapment with Supercharged Arginine-Rich Peptides.Impacts of ABCB1 (G1199A) polymorphism on resistance, uptake, and efflux to steroid drugs.
P2860
Q26769800-45EF8CD8-977C-430E-B265-1A457D59A44BQ31078024-8B91A110-A5C0-41F0-8FC8-9A38466F1DD4Q33562478-098DB280-8109-4570-B8A5-23C543E57CC2Q35806512-87FC7882-7181-4677-978B-9CD8E320F0B9Q37039034-C5B991FB-8BC1-4E60-AB6E-9E0FDCD6F4EEQ38214156-613ACD56-10E6-4408-BCD6-446569D4F43FQ38307864-444AEFF7-F2F5-47C6-BE46-BAD8ED68B9B6Q38808440-DAEB21C8-3BD3-4AC7-A1B9-764FB8961B25Q38881439-CE3B1326-17A5-4DD4-91DC-3593A6C42FD3Q39043463-83C3C65E-319C-4DCE-AB3A-6EDA0B8F8A9BQ39494684-A0F0D45C-B087-4CD0-B922-81A6E3B96B39Q39581513-C275CB28-CB98-4F75-9A7D-E4A6CAD3041AQ40369050-E690D02F-0E66-424A-B0FD-ACEBCE72B399Q41208099-C9E07DE1-0CDF-41B6-949E-65C430817197Q45224394-AEF15907-72E9-438B-86FE-FC128B308B42Q47728958-6CD01915-4446-438F-9B6C-D078952E6A83Q53799638-1C4F680A-6014-487B-9ECF-59A0570BF102
P2860
Cellular uptake but low permeation of human calcitonin-derived cell penetrating peptides and Tat(47-57) through well-differentiated epithelial models.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Cellular uptake but low permea ...... ferentiated epithelial models.
@ast
Cellular uptake but low permea ...... ferentiated epithelial models.
@en
type
label
Cellular uptake but low permea ...... ferentiated epithelial models.
@ast
Cellular uptake but low permea ...... ferentiated epithelial models.
@en
prefLabel
Cellular uptake but low permea ...... ferentiated epithelial models.
@ast
Cellular uptake but low permea ...... ferentiated epithelial models.
@en
P2093
P1476
Cellular uptake but low permea ...... ferentiated epithelial models.
@en
P2093
Annette G Beck-Sickinger
Hanne M Nielsen
Hans P Merkle
Rachel Tréhin
Ulrike Krauss
P304
P356
10.1023/B:PHAM.0000033013.45204.C3
P577
2004-07-01T00:00:00Z